EPISODE · May 7, 2026 · 1 MIN
The End of the “Wait and See” Era: How Blood Tests Are Revolutionizing Neurology
from TheBrief.Health · host TheBrief.Health
High-accuracy Alzheimer’s blood tests using biomarkers like p-tau217 may enable earlier, more accessible diagnosis, improving treatment access, precision staging, and personalized neurodegenerative care worldwide.
What this episode covers
High-accuracy Alzheimer’s blood tests using biomarkers like p-tau217 may enable earlier, more accessible diagnosis, improving treatment access, precision staging, and personalized neurodegenerative care worldwide.
NOW PLAYING
The End of the “Wait and See” Era: How Blood Tests Are Revolutionizing Neurology
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m